|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 51.19 USD | +1.45% |
|
+4.28% | -46.31% |
| 08-07 | Espiria Hållbar Framtid rose 2.5 percent in July - cut holdings in Bristol Myers Squibb, Merck and Novo Nordisk | FW |
| 08-05 | Wall Street warms to healthcare stocks as tech trade faces turbulence | RE |
| Market Cap | 74.19B 64.29B 60.19B 54.92B 103B 7,076B 105B 706B 276B 3,542B 279B 272B 11,815B | P/E 2026 * |
19.1x | P/E 2027 * | 19.9x |
|---|---|---|---|---|---|
| Enterprise Value | 82.9B 71.84B 67.26B 61.37B 115B 7,907B 117B 789B 309B 3,958B 311B 304B 13,204B | EV / Sales 2026 * |
3.88x | EV / Sales 2027 * | 3.57x |
| Free-Float |
82.49% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Boston Scientific Corporation
| 1 day | +1.45% | ||
| 1 week | +4.28% | ||
| Current month | +9.54% | ||
| 1 month | +14.34% | ||
| 3 months | -4.08% | ||
| 6 months | -30.33% | ||
| Current year | -46.31% |
| 1 week | 48.88 |  | 51.5 |
| 1 month | 42.2 | | 51.5 |
| Current year | 42.2 | | 100.9 |
| 1 year | 42.2 | | 109.5 |
| 3 years | 42.2 | | 109.5 |
| 5 years | 34.98 | | 109.5 |
| 10 years | 19.67 | | 109.5 |
| Manager | Title | Age | Since |
|---|---|---|---|
Michael Mahoney
CEO | Chief Executive Officer | 61 | 01/11/2011 |
Jonathan Monson
DFI | Director of Finance/CFO | 52 | 30/06/2025 |
Kenneth Stein
CTO | Chief Tech/Sci/R&D Officer | - | 01/09/2009 |
| Director | Title | Age | Since |
|---|---|---|---|
Michael Mahoney
CHM | Chairman | 61 | 03/05/2016 |
Edward Ludwig
BRD | Director/Board Member | 74 | 01/03/2014 |
Ellen Zane
BRD | Director/Board Member | 74 | 15/04/2016 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 05/08/26 | Buy | Director | 2,100 | 0.0001% | ||
| 04/08/26 | Buy | Director | 140 | 0.0000% | ||
| 03/08/26 | Buy | Chief Executive Officer | 208,359 | 0.0141% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.45% | +4.28% | -50.18% | +0.31% | 74.19B | |
| +0.89% | +7.13% | +30.84% | +11.26% | 224B | |
| -0.92% | +6.50% | +3.84% | -18.78% | 146B | |
| +2.00% | +8.95% | -14.97% | +31.77% | 142B | |
| +1.77% | +4.53% | +19.83% | +17.94% | 53.99B | |
| -0.53% | -0.03% | -15.22% | -16.73% | 50.85B | |
| +0.52% | +7.39% | +30.98% | +17.84% | 42.22B | |
| +0.78% | +4.78% | +48.59% | +42.29% | 40.75B | |
| -0.26% | +3.54% | -0.34% | +1.62% | 32.86B | |
| +2.18% | +0.76% | -20.92% | +25.28% | 32.43B | |
| Average | +0.76% | +220.33% | +3.25% | +11.28% | 83.86B | |
| Weighted average by Cap. | +0.75% | +309.24% | +5.38% | +9.27% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 21.37B 18.52B 17.33B 15.82B 29.76B 2,038B 30.26B 203B 79.63B 1,020B 80.22B 78.48B 3,403B | 22.34B 19.36B 18.12B 16.53B 31.11B 2,130B 31.64B 212B 83.25B 1,066B 83.87B 82.04B 3,558B |
| Net income | 3.84B 3.33B 3.12B 2.84B 5.35B 367B 5.44B 36.56B 14.32B 183B 14.43B 14.12B 612B | 3.74B 3.24B 3.03B 2.77B 5.21B 357B 5.3B 35.57B 13.94B 178B 14.04B 13.73B 595B |
| Net Debt | 8.72B 7.55B 7.07B 6.45B 12.14B 831B 12.35B 82.92B 32.49B 416B 32.73B 32.02B 1,388B | 5.45B 4.72B 4.42B 4.04B 7.59B 520B 7.72B 51.86B 20.32B 260B 20.47B 20.02B 868B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 11/08/26 | $51.19 | +1.45% | 13,453,112 |
| 10/08/26 | $50.46 | +2.33% | 18,994,452 |
| 07/08/26 | $49.31 | +0.02% | 11,447,002 |
| 06/08/26 | $49.30 | +3.27% | 21,398,972 |
| 05/08/26 | $47.74 | -2.75% | 16,512,147 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- BSX Stock
Select your edition
All financial news and data tailored to specific country editions
